Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Federal Trade Commission
Medtronic
McKesson
Cantor Fitzgerald
Chinese Patent Office
Moodys
Harvard Business School

Generated: April 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,237,068

« Back to Dashboard

Summary for Patent: 4,237,068
Title: Primary aminoacylanilides
Abstract:Primary amino acylanilides of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen, methyl, ethyl and propyl, R.sub.2 is selected from the group consisting of methyl, ethyl, chlorine, methoxy and ethoxy, R.sub.3 is selected from the group consisting of hydrogen and methyl, R.sub.4 is selected from the group consisting of hydrogen, methyl, and a C.sub.1 -C.sub.4 alkoxy group, R.sub.6 is selected from the group consisting of methyl, ethyl, chlorine, methoxy and ethoxy, R.sub.7 is hydrogen, methyl or ethyl, R.sub.8 is hydrogen, R.sub.9 is hydrogen, methyl or ethyl, R.sub.10 is hydrogen, and n is 0 or 1, with the provisions that (a) when n is 0, R.sub.8 can also be methyl; (b) when n is 1, and R.sub.7 is hydrogen, and R.sub.9 is hydrogen or methyl, then R.sub.10 can also be methyl; (c) when R.sub.1 is hydrogen, R.sub.2 is methyl, R.sub.3 is hydrogen, R.sub.6 is methyl, R.sub.7 is hydrogen, R.sub.8 is hydrogen, and n is 0, then R.sub.4 can be ethoxy or propoxy only; (d) when R.sub.1 is hydrogen, R.sub.2 is methyl, R.sub.3, R.sub.4, R.sub.7 and R.sub.8 are hydrogen, and n is 0, then R.sub.6 is methoxy, ethoxy, or ethyl only; and the therapeutically acceptable salts thereof. Compounds of this type have been found to be effective longlasting cardiac antiarrhythmic agents, especially when administered by the oral route.
Inventor(s): Boyes; Robert N. (Auburn, MA), Duce; Benjamin R. (Westborough, MA), Smith; Emil R. (Shrewsbury, MA), Byrnes; Eugene W. (Holden, MA)
Assignee: Astra Pharmaceutical Products, Inc. (Worcester, MA)
Application Number:05/929,916
Patent Claims: 1. The compound 2-amino-2',6'-propionoxylidide, and the pharmaceutically acceptable salts thereof.

2. The compound (+)-2-amino-2',6'-propionoxylidide, and the pharmaceutically acceptable salts thereof.

3. The compound (-)-2-amino-2',6'-propionoxylidide, and the pharmaceutically acceptable salts thereof.

4. The compound 2-amino-2'-ethyl-6'-methylpropionanilide, and the pharmaceutically acceptable salts thereof.

5. The compound 3-amino-2',6'-butyroxylidide, and the pharmaceutically acceptable salts thereof.

6. The compound 2-amino-2',6'-diethylpropionanilide, and the pharmaceutically acceptable salts thereof.

7. The compound 3-amino-2',4',6'-propionomesidide, and the pharmaceutically acceptable salts thereof.

8. The compound 2-amino-4'-butoxy-2',6'-dimethylpropionanilide, and the pharmaceutically acceptable salts thereof.

9. The compound 3-amino-2'-methyl-6'-ethylbutyranilide, and the pharmaceutically acceptable salts thereof.

10. The compound 3-amino-2',4',6'-butyromesidide, and the pharmaceutically acceptable salts thereof.

11. The compound 3-amino-2',6'-valeroxylidide, and the pharmaceutically acceptable salts thereof.

12. The compound 3-amino-2',6'-propionoxylidide and the pharmaceutically acceptable salts thereof.

13. The compound 2-amino-2',6'-butyroxylidide and the pharmaceutically acceptable salts thereof.

14. The compound 3-amino-2-methyl-2',6'-propionoxylidide and the pharmaceutically acceptable salts thereof.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Boehringer Ingelheim
Federal Trade Commission
Healthtrust
Cantor Fitzgerald
Teva
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.